HCPLive podcast examines tirzepatide's new cardiovascular indication
The Diabetes Dialogue episode pairs discussion of the incretin label expansion with the STAREE statin trial in older adults.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 10 03:00 ETSource: HCPLive
The wire
- 01HCPLive's Diabetes Dialogue podcast covers tirzepatide's newly added cardiovascular indication alongside results from the STAREE statin trial.
- 02Prescribers weighing incretin therapy in patients with cardiovascular risk will want the details of what the expanded indication covers.
- 03The episode listing gives no further detail on the indication's wording or the supporting data; clinicians should check the current label.
From the source
Read at hcplive.comDiabetes Dialogue: Tirzepatide's New CV Indication and the STAREE Statin Trial